AI assistant
LISI S.A. — Earnings Release 2015
Feb 17, 2016
1484_10-k_2016-02-17_d5a148d7-adc3-4b13-9863-84efaaddc3b6.pdf
Earnings Release
Open in viewerOpens in your device viewer
Press release Belfort, February 17, 2016
LISI REPORTS ANOTHER YEAR OF EARNINGS GROWTH IN 2015
- Revenue up 11.6 % at €1.46 billion
- o Full-year consolidation of Manoir Aerospace: + €88m
- o Strong impact of currency fluctuations: + €42m
- o Organic growth: +1.6%, with market share gains from new products across all divisions
- EBIT margin in line with the strategic objective of 10.0%;EBIT operating profit up 11.3%
- Financial strength maintained:
- o Free Cash Flow* remains positive (€39.6m) after record capital expenditure (€111m)
- o Net debt reduced by €24.6m, with net debt to EBITDA ratio below 1
- Dividend: €0.39 per share
- Solid prospects
February 17, 2016 – LISI's Board of Directors met under the chairmanship of Mr. Gilles Kohler and reviewed the final audited financial statements for the financial year ended December 31, 2015. They will be submitted for approval to the General Meeting on April 27, 2016.
| 12 months ending December 31, | 2015 | 2014 | Changes | ||||
|---|---|---|---|---|---|---|---|
| Key elements of the income statement | |||||||
| Revenue | €m | 1,458.1 | 1,306.5 | + 11.6 % | |||
| Earnings Before Interest, Tax, Depreciation & | €m | 204.1 | 193.2 | + 5.6 % | |||
| Amortization (EBITDA) | |||||||
| EBITDA margin | % | 14.0 | 14.8 | - 0.8 pt | |||
| Earnings Before Interest & Tax (EBIT) | €m | 146.5 | 131.7 | + 11.3 % | |||
| EBIT margin | % | 10.0 | 10.1 | - 0.1 pt | |||
| Earnings attributable to equity holders of the | €m | 81.8 | 81.4 | + 0.5 % | |||
| company | |||||||
| Net earnings per share | € | 1.55 | 1.55 | - | |||
| Key elements of the cash flow statements | |||||||
| Operating cash flow | €m | 154.2 | 140.8 | + €13.4m | |||
| Net capital expenditure | €m | - 111.5 | - 90.6 | + €20.9m | |||
| Free Cash Flow * | €m | 39.6 | 45.6 | - €6.0m | |||
| Key elements of the financial structure | |||||||
| Net debt | €m | 156.6 | 181.2 | - €24.6m | |||
| Ratio of net debt to equity | 19.7 % | 25.6 % | -5.9 pts |
* Free Cash Flow: operating cash flow minus net industrial capital expenditure and changes in working capital requirements
Revenue at €1,458m (up 11.6%), including organic growth of 1.6%
At €1,458.1m, consolidated net sales for fiscal 2015, up 11.6%, reflect the following positive elements:
- The contribution of Manoir Aerospace, consolidated since June 5, 2014, amounted to €88m or 6.0% of consolidated revenues and 9.5% of LISI AEROSPACE's revenue. The division now accounts for 64% of Group sales.
- The decline of the euro against most currencies, primarily the dollar, generated an impact of €42m.
- All activities recorded market share gains from new products.
On a constant exchange rate and scope basis, the - 0.9% variation in revenues in H2 compared to 2014 marks a sharp recovery in the last quarter: +1.2% on a high comparison basis (+8.6% in Q4 2014), after a third quarter that was particularly impacted by the deceleration of the automotive industry in China.
| €m | LISI Consolidated |
of which LISI AEROSPACE |
of which LISI AUTOMOTIVE |
of which LISI MEDICAL |
|---|---|---|---|---|
| Q1 | 381.6 | 240.4 | 122.8 | 18.6 |
| Q2 | 374.2 | 236.9 | 118.3 | 19.2 |
| Q3 | 339.3 | 216.5 | 104.7 | 18.3 |
| Q4 | 363.0 | 235.7 | 108.8 | 18.6 |
| 2015 | 1458.1 | 929.6 | 454.6 | 74.8 |
Organic growth continues to be positive across all divisions.
The fourth quarter was quite dynamic in all three divisions, with an overall increase of +3.6%, of which +2.4% due to currency effects.
LISI AEROSPACE stood out in the Fasteners segment thanks to the implementation of new contracts and sustained activity levels in the United States. The Structural Components segment expects production output to increase in the near future for products that are still in engineering stage.
The LISI AUTOMOTIVE division confirmed its recovery after the adjustment of the Chinese market that mainly affected the third quarter. A +1.4% rise in sales was particularly noticeable in the clipped solutions segment.
LISI MEDICAL is reaching a plateau after a high-growth start of the year.
At 10.0%, EBIT margin margin is in line with the strategic objective
2015 is the fifth consecutive year of growth for all the management indicators in absolute terms.
At over €200m, EBITDA, up +5.6%, represented 14.0% of sales. Operating profit (EBIT) rose by €15m (+11.3%) to €146.5m. It is interesting to note that despite the lower number of working days between the second half of 2014 and the same period in 2015 on a constant scope basis, the operating margin increased from 8.8% to 9.7%. Over the full year, it amounted to 10.0% of sales, virtually unchanged compared to 2014 despite the unfavorable effect of Manoir Aerospace.
Such resilience reflects the improved operational quality across all Group activities. It is therefore legitimate to consider this level of 10.0% to be close to the standard set by the Group, given its business mix. The contribution from productivity gains resulting from the LEAP program (LISI Excellence Achievement Program), and the effects of the ambitious capital expenditure plan, were instrumental in this performance.
While the Aerospace Division remains the largest contributor to EBIT (€124.3m), the Automotive Division saw its profitability improve very clearly (at +€18.0m), particularly towards the end of the year. The contribution of the Medical Division is also improving (at +€4.1m).
Loan-related interest expenses were limited to €5.0m (€4.7m in 2014). The Group's exposure to currencies other than the euro and, in particular, the US dollar, is rising sharply, which required the establishment of hedging instruments for most part of the coming four years. The impact of these instruments resulted in an expense of €6.5m in 2015 (compared to a profit of €3.2m in 2014).
Non-operating costs related to the closure of the old City of Industry plant (USA) and the Villefranchede-Rouergue plant, weighed on the non-operating result for €5.8m.
The tax expense, calculated on the basis of the corporation tax as a percentage of the net income before taxes, reflects an effective average rate of tax of 34.3%, slightly up compared with 2014 (34.4 %).
At €81.8m, net income is equivalent to that of 2014 (€81.4m).
Based upon the results, the Group will seek the Shareholders' General Meeting's approval to set the dividend at €0."9 per share for the 2015 financial year.
Financial structure remains robust after two years of significant capital expenditure programs
Proper control of inventory levels and lower customer payment delays have helped reduce the consolidated working capital from 90 days in 2014 to 76 days at the end of 2015 (these figures take into account the consolidation of the Manoir Aerospace Group).
In line with previous years, LISI has maintained a steady pace of capital expenditure that reached a historical high of €111.5m. In 2015, these programs were mainly devoted to production equipment and the launch of several new plants (City of Industry - United States, Dorval - Canada). With €154.2m of cash flow, the Group was able to easily cope with these expenses, while still generating a positive cash surplus from operations (Free Cash Flow) of €39.6m.
Net debt decreased by almost €25m to €156.6m as at December 31, 2015, or 19.7% of equity (25.6% in 2014). LISI's financial structure enabled the Group to fund the acquisition of the Manoir Aerospace Group in June 2014 and its ambitious investment plan of over €200m in the last two years, while maintaining robust ratios.
The return on capital employed (before taxes) amounted to 15.9% at year end, to be compared with 16.6% as at December 31, 2014. The capital employed increased in value by €1,039m (compared with €996m in 2014).
LISI AEROSPACE
- Stable volumes, before the sharp rise of new programs expected in 2017
- Revenue supported by the very positive contribution from the US dollar strength against the euro (+€38.1m)
- Free Cash Flow∗ very positive, despite record level of capital expenditure (+€69m). Fasteners business extremely satisfactory
- Creation of LISI AEROSPACE Additive Manufacturing, 60% owned by LISI AEROSPACE and 40% owned by POLY-SHAPE, dedicated to the design and production of mechanical parts through 3D printing
| 2015 | 2014 | Change | |
|---|---|---|---|
| 2% | |||
| Revenue (in €m) | 929.6 | 788.1 | At constant scope and exchange rates |
| EBIT margin | 13.4 % | 14.5% | - 1.1 pts |
| Operating cash flow surplus ∗ "Free Cash Flow " (€m) |
41.7 | 43.9 | - €2.2m |
| As a % of revenue | 4.5 % | 5.6 % | - 1.1 pts |
LISI AUTOMOTIVE
- Gains in market share in a fairly dynamic environment
- Initial results of the vast industrial reorganization plan launched in 2012 (application hardware, security components, clips)
- Strong rebound of Free Cash Flow∗ (+€9.6m) due to the significant improvement in working capital requirements
| 2015 | 2014 | Change | |
|---|---|---|---|
| Revenue (in €m) | 454.6 | 448.3 | + 0.6 % |
| At constant scope and exchange rates |
|||
| EBIT margin | 4.0 % | 3.0 % | + 1.0 pt |
| Operating cash flow surplus ∗ "Free Cash Flow " (€m) |
- €3.1m | - 12.7 | + €9.6m |
| As a % of revenue | n.a. | n.a. | n.a |
∗ Free Cash Flow: net operating cash flow minus net capital expenditure and changes in working capital requirements
LISI MEDICAL
- Market rather buyoant
- Further improvement in operating margin
- Return to positive Free Cash Flow*, despite capital expenditure remaining significant
| 2015 | 2014 | Change | |
|---|---|---|---|
| Revenue (in €m) | + 3.2 % | ||
| 74.8 | 71.1 | At constant scope and exchange rates |
|
| EBIT margin | 5.5 % | 4.9 % | + 0.6 pt |
| ∗ Free Cash Flow " (€m) |
1.7 | - 1.0 | + €2.7m |
| As a % of revenue | 2.3 % | n.a. | n.a. |
OUTLOOK
LISI is positioned in growing markets. The Aerospace Division should only start benefitting from higher production output from the end of 2016. In this perspective, it continues to modernize its means of production and to industrialize new products. It also invests in long-term projects such as the development of the "Optiblind" automated assembly system, the implementation of a "robot" project. Another area of focus is the creation of LISI AEROSPACE Additive Manufacturing with POLY SHAPE, the European leader in additive manufacturing with which the Group signed on 17 December 2015, an agreement to create a joint company, namely LISI AEROSPACE Additive Manufacturing. 60% owned by LISI AEROSPACE and 40% owned by POLY-SHAPE, the new organization aims to provide aviation customers with a product offering that incorporates additive technologies in the design and production of machine parts using 3D printing.
All these initiatives aim to position LISI AEROSPACE in the long term as the development partner of all major global aerospace programs.
The automotive markets look well oriented, at least for the first part of the year in Europe and the United States. This upward trend, reinforced by the steady increase in volumes of new automotive products, is expected to benefit LISI AUTOMOTIVE. Logistics which improved towards the end of 2015, allow for a smooth operational start into 2016, devoid of major difficulties. The goal remains to continue the progress achieved over the last three years and to improve the operating profitability in a sustainable manner.
LISI MEDICAL should also follow a similar path and leverage on its consolidated fundamentals.
At the same time, the more demanding customers and the large number of new projects under development or industrialization make it even more necessary to implement major cross-functional projects such as LEAP (LISI Excellence Achievement Program), EHSE (HSE Excellence) and COS (Controlling Operating System).
Thus, by alternating organic growth and targeted acquisitions, the economic model of the LISI Group, whose markets are all growing, should enable it to continue generating a double-digit operating margin and to maintain positive Free Cash Flow∗ .
∗ Free Cash Flow: net operating cash flow minus net capital expenditure and changes in working capital requirements
NEW ORGANIZATION OF LISI's BOARD
At that meeting, the Board confirmed the decision taken in its meeting of October 21, 2015 to separate the functions of Chairman and Chief Executive Officer. Mr Gilles KOHLER was confirmed in his role as Chairman of the Board and Mr Emmanuel VIELLARD was appointed as CEO and Mr Jean-Philippe KOHLER as Managing Director. These appointments were made with effect from March 1, 2016.
Furthermore, Mrs Lise NOBRE Vice-President of the Board of Directors.
Contact
Emmanuel Viellard Tel: +33 (0)3 84 57 00 77 E-mail: [email protected] Website: www.lisi-group.com
The next announcements will be released after close of trading on Paris Euronext
Q1 2016 financial information: April 28, 2016 Shareholders' General Meeting: April 27, 2016 H1 2016 results: July 28, 2016 Q3 2016 financial Information: October 26, 2016
The LISI share is listed on Euronext Paris compartment A and belongs to the indices CAC® AERO & DEF., CAC® All Shares, CAC® – All Tradable, CAC® Industrials, CAC® Mid & Small, et CAC® Small, under ISIN code: FR 0000050353. LISI is a worldwide leading manufacturer of fasteners and assembly components for the Aerospace, Automotive, and medical implants industries.
Reuters:GFII.PA Bloomberg:FII FP
LISI Group consolidated income statement
| (in €'000) | Notes | 31/12/2015 | 12/31/2014 restated * |
|---|---|---|---|
| Pre-tax sales | 1 458 052 | 1 306 530 | |
| Changes in stock, finished products and production in progress | 20 405 | 1 682 | |
| Total production Other revenues (a) |
1 478 457 13 083 |
1 308 213 17 440 |
|
| Total operating revenues | 1 491 540 | 1 325 653 | |
| Consumed goods Other purchases and external expenses |
(398 213) (308 415) |
(344 613) (265 077) |
|
| Value added | 784 912 | 715 963 | |
| Taxes and duties (b) Personnel expenses (including temporary employees) (c) |
(11 590) (569 236) |
(9 357) (513 273) |
|
| EBITDA | 204 086 | 193 333 | |
| Depreciation Net provisions |
(73 787) 16 194 |
(64 630) 3 097 |
|
| EBIT | 146 493 | 131 800 | |
| Non-recurring operating expenses Non-recurring operating revenues |
(11 148) 5 308 |
(10 852) 8 058 |
|
| Operating profit | 140 652 | 129 005 | |
| Financing expenses and revenue on cash Revenue on cash Financing expenses Other interest revenue and expenses Other financial items Other interest expenses |
(6 163) 983 (7 146) (9 819) 35 466 (45 285) |
(6 410) 807 (7 217) 1 563 28 285 (26 722) |
|
| Taxes (of which CVAE (Tax on Companies' Added Value)) (b) | (42 741) | (42 631) | |
| Share of net income of companies accounted for by the equity method | (71) | 31 | |
| Profit (loss) for the period | 81 859 | 81 557 | |
| attributable as company shareholders' equity Interest not granting control over the company |
81 764 95 |
81 464 93 |
|
| Earnings per share (in €) | 1,55 | 1,55 | |
| Diluted earnings per share (in €) | 1,55 | 1,55 |
a/ In order to provide readers of the financial statements with better information that is in accordance with international standards, in the 2015 financial statements the Company has continued classifying revenues related to CIR (Research Tax Credit) as "Other Revenues".
LISI Group consolidated balance sheet
ASSETS
| (in €'000) Notes |
31/12/2015 | 12/31/2014 restated * |
|---|---|---|
| LONG-TERM ASSETS | ||
| Goodwill Other intangible assets Tangible assets Long-term financial assets Deferred tax assets Other long-term assets |
260 334 14 923 481 354 10 585 19 838 924 |
256 511 16 349 431 847 9 357 22 288 976 |
| Total long-term assets | 787 958 | 737 330 |
| SHORT-TERM ASSETS | ||
| Inventories Taxes – Claim on the state Trade and other receivables Cash and cash equivalents |
336 127 23 819 215 291 125 812 |
316 989 5 744 216 107 110 818 |
| Total short-term assets | 701 050 | 649 657 |
| TOTAL ASSETS | 1 489 008 | 1 386 987 |
TOTAL EQUITY AND LIABILITIES
| (in €'000) | Notes | 31/12/2015 | 12/31/2014 restated * |
|---|---|---|---|
| SHAREHOLDERS' EQUITY | |||
| Share capital Additional paid-in capital Treasury shars Consolidated reserves Conversion reserves Other income and expenses recorded directly as shareholders' equity Profit (loss) for the period |
21 610 72 584 (14 740) 603 092 30 598 (2 653) 81 764 |
21 610 72 584 (15 042) 543 542 11 248 (6 505) 81 464 |
|
| Total shareholders' equity - Group's share | 792 256 | 708 902 | |
| Minority interests | 1 189 | 1 117 | |
| Total shareholders' equity | 793 446 | 710 023 | |
| LONG-TERM LIABILITIES | |||
| Long-term provisions Long-term borrowings Other long-term liabilities Deferred tax liabilities |
73 274 230 145 12 591 31 527 |
83 474 245 690 9 071 21 584 |
|
| Total long-term liabilities | 347 537 | 359 819 | |
| SHORT-TERM LIABILITIES | |||
| Short-term provisions Short-term borrowings* Trade and other accounts payable Taxes due |
15 350 52 285 278 181 2 211 |
22 907 46 363 242 312 5 566 |
|
| Total short-term liabilities | 348 026 | 317 147 | |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 1 489 008 | 1 386 987 | |
| * of which banking facilities | 9 243 | 10 066 |
LISI Group consolidated cash flow table
| (in €'000) | 31/12/2015 | 12/31/2014 restated * |
|---|---|---|
| Operating activities | ||
| Net earnings Elim. of the income of companies accounted for by the equity method |
81 859 71 |
81 557 -31 |
| Elimination of net expenses not affecting cash flows: | ||
| - Depreciation and non-recurrent financial provisions - Changes in deferred taxes |
71 284 10 554 |
66 886 (274) |
| - Income on disposals, provisions for liabilities and others Gross cash flow margin |
(7 140) 156 628 |
(4 490) 143 648 |
| Net changes in provisions provided by or used for current operations Operating cash flow |
(2 476) 154 153 |
(2 757) 140 891 |
| Income tax expense (revenue) | 32 187 | 42 905 |
| Elimination of net borrowing costs Effect of changes in inventory on cash |
5 133 (18 066) |
4 837 (8 557) |
| Effect of changes in accounts receivable and accounts payable Net cash provided by or used for operations before tax |
36 455 209 861 |
(4 427) 175 649 |
| Taxes paid | (53 641) | (34 577) |
| Cash provided by or used for operations (A) | 156 220 | 141 072 |
| Investment activities | ||
| Acquisition of consolidated companies Cash acquired |
(47) | (127 735) 8 841 |
| Acquisition of tangible and intangible fixed assets Acquisition of financial assets |
(112 803) | (92 548) |
| Change in granted loans and advances Investment subsidies received |
227 | (215) |
| Dividends received Total cash used for investment activities |
(112 623) | (211 657) |
| Divested cash | ||
| Disposal of consolidated companies Disposal of tangible and intangible fixed assets |
1 341 | 1 923 |
| Disposal of financial assets Total cash from disposals |
1 341 | 1 923 |
| Cash provided by or used for investment activities (B) | (111 281) | (209 733) |
| Financing activities | ||
| Capital increase | 1 838 | |
| Net disposal (acquisition) of treasury shares Dividends paid to shareholders of the Group |
(19 467) | (17 820) |
| Dividends paid to minority interests of consolidated companies Total cash from equity operations |
(19 467) | (15 982) |
| Issue of long-term loans | 9 166 | 155 307 |
| Issue of short-term loans Repayment of long-term loans |
40 926 (5 301) |
467 (22 903) |
| Repayment of short-term loans | (54 354) | (33 105) |
| Net interest expense paid Total cash from operations on loans and other financial liabilities |
(5 134) (14 698) |
(4 837) 94 928 |
| Cash provided by or used for financing activities (C) | (34 164) | 78 947 |
| Effect of change in foreign exchange rates (D) | 4 741 | 5 597 |
| Effect of adjustments in treasury shares (D) * | 302 | (908) |
| Changes in net cash (A+B+C+D) | 15 818 | 14 975 |
| Cash at January 1st (E) | 100 751 | 85 776 |
| Cash at year end (A+B+C+D+E) | 116 569 | 100 751 |
| Cash and cash equivalents Short-term banking facilities |
125 812 (9 243) |
110 818 (10 066) |
Change in LISI Group consolidated shareholders' equity
| ( ) in € '000 |
Sh are cap ital |
Ca ed pre ital- link p miu ms |
Tre ry sha asu rs |
Co lida ted nso res erv es |
Co rsio n res nve erv es |
Oth er i nco me and ex pen ses ord ed dire ctly rec sha reh old ' as ers ity equ |
Pro fit f he or t iod per , gr oup sha re |
Gro 's s har up e of sha reh old ' ers ity equ |
Min ori ty inte ts res |
Tot al sha reh old ' ers ity equ |
|---|---|---|---|---|---|---|---|---|---|---|
| Pub lish ed sha reh old ' eq uity Jan at 1, 2 014 ers uar y |
573 21 |
70 803 |
( 135 ) 14 |
45 487 8 |
( ) 12 078 |
( 84) 3 0 |
74 639 |
625 17 9 |
53 1 2 |
626 43 4 |
| Res * tate nts me |
951 | 59 | 1 0 10 |
1 0 10 |
||||||
| Res tate d s har eho lde rs' ity at J 1, 201 4 equ anu ary |
21 573 |
70 803 |
( ) 14 135 |
488 40 9 |
( ) 12 078 |
( 84) 3 0 |
74 698 |
626 18 6 |
1 2 53 |
627 43 9 |
| Pro fit ( loss ) for the riod N (a ) pe |
81 464 |
81 464 |
94 | 81 558 |
||||||
| Tra nsla tion dif fere ntia l ( b) |
23 326 |
23 326 |
14 | 23 340 |
||||||
| Pay in sha (c ) nts me res |
784 | 784 | 784 | |||||||
| Ca ital inc p rea se |
37 | 1 7 81 |
1 8 18 |
0 | 1 8 18 |
|||||
| Res of har ( d) tate nts trea me sur y s es |
( 907 ) |
-90 7 |
( 907 ) |
|||||||
| Res r IA S19 (g ) tate nts me as pe |
( 5 1 86) |
-5 1 86 |
( 5 1 86) |
|||||||
| Ap iati of N -1 e ing pro pr on arn s |
74 698 |
( ) 74 698 |
0 | 0 | ||||||
| Ch e in ang sc ope |
( ) 988 |
-98 8 |
( ) 243 |
( 31) 1 2 |
||||||
| Div ide nds dis trib ute d |
( ) 17 820 |
-17 82 0 |
( ) 17 820 |
|||||||
| Res of fina nci al i s ( f) tate nts nst ent me rum |
981 | 981 | 981 | |||||||
| Va riou s (e ) |
( 757 ) |
-75 7 |
( 757 ) |
|||||||
| Res d s har eho lde rs' ity at D mb er 3 1, 2 014 * tate equ ece |
21 610 |
72 584 |
( 15 042 ) |
543 54 2 |
11 248 |
( 6 5 05) |
81 464 |
708 90 1 |
1 1 18 |
710 01 9 |
| inc lud ing to tal and ste d fo r th rev enu es ex pen ses po e iod (a ) + ( b) + ( c) + ( d) + ( e ) + ( f) per |
23 326 |
( 3 4 21) |
81 464 |
101 36 9 |
108 | 101 47 7 |
||||
| ( ) in € '000 |
Sh are cap ital |
Ca ed pre ital- link p miu ms ( .3) Not e 7 |
Tre ry sha asu rs |
Co lida ted nso res erv es |
Co rsio n res nve erv es |
Oth er i nco me and ex pen ses ord ed dire ctly rec sha reh old ' as ers ity equ |
Pro fit f he or t iod per , gr oup sha re |
Gro 's s har up e of sha reh old ' ers ity equ |
Min ori ty inte ts res |
Tot al sha reh old ' ers ity equ |
| Res tate d s har eho lde rs' ity at J 1, 201 5 * equ anu ary |
21 610 |
72 584 |
( ) 15 042 |
543 54 2 |
11 248 |
( 05) 6 5 |
81 464 |
708 90 1 |
1 1 18 |
710 01 9 |
| Pro fit ( loss ) for the riod N (a ) pe |
81 764 |
81 764 |
95 | 81 859 |
||||||
| Tra nsla tion dif fere ntia l ( b) |
19 350 |
19 350 |
1 | 19 351 |
||||||
| Pay nts in sha (c ) me res |
1 8 86 |
1 8 86 |
1 8 86 |
|||||||
| Res of har ( d) tate nts trea me sur y s es |
302 | 100 | 402 | 402 | ||||||
| Res r IA S19 (g ) tate nts me as pe |
4 0 74 |
4 0 74 |
4 0 74 |
|||||||
| Ap iati of N -1 e ing pro pr on arn s |
81 464 |
( 81 464 ) |
0 | 0 | ||||||
| Ch e in ang sc ope |
0 | 0 | 0 | |||||||
| Div ide nds dis trib d ute |
( ) 19 467 |
( 19 467 ) |
0 | ( ) 19 467 |
||||||
| Res of fina nci al i s ( f) tate nts nst ent me rum |
( 07) 2 2 |
( 2 2 07) |
( 25) |
( 32) 2 2 |
||||||
| Va riou s (e ) |
( 2 4 47) |
( 2 4 47) |
( 2 4 47) |
|||||||
| Sh hol der s' e ity at D mb er 3 1, 2 015 are qu ece |
21 610 |
72 584 |
( 14 740 ) |
603 09 2 |
30 598 |
( 2 6 53) |
81 764 |
792 25 6 |
1 1 89 |
793 44 6 |
| inc lud ing tal and d fo r th to ste rev enu es ex pen ses po e |
19 350 |
3 8 52 |
81 764 |
104 96 6 |
96 | 105 06 2 |
||||
| iod (a ) + ( b) + ( c) + ( d) + ( e ) + ( f) + (g ) per |